Towards a global health
The future of EDCTP

Lara Pandya

Expected to start in 2021, the preparations for Horizon Europe – the ninth European Union (EU) Framework Programme for Research and Innovation – are in full swing. Although the current EDCTP programme is expected to run until the end of 2024, it is anticipated that the ambitious successor programme, building on the results and successes of EDCTP1 and EDCTP2, will be launched under Horizon Europe as the European Union - Africa Global Health Partnership.

Preparations for the EU-Africa Global Health Partnership/ EDCTP3 have been underway since 2018 through a consultative process with EDCTP’s stakeholders. This included a series of high-level dialogue events held on 9-10 July 2018 in Ghana, 30 August 2018 in Senegal, and 17 September 2018 in Portugal. These were followed up by a dedicated session at the Ninth EDCTP Forum on 18 September 2018, a side event at the World Health Assembly in Switzerland on 27 May 2019, and various meetings with EDCTP partners.

In 2019, the European Commission launched an Impact Assessment process for the candidate partnership, in order to know which type of partnerships would be the most convenient policy option for the follow-up programme. In parallel, the EDCTP Association Members and the EDCTP Scientific Advisory Committee jointly developed a draft Proposal and Strategic Research and Innovation Agenda for the envisaged Global Health Partnership/EDCTP3. Numerous EDCTP 

The scrutiny and final selection of candidate European Partnerships, with the EU-Africa Global Health Partnership/EDCTP3 as one of these candidate partnerships, is being carried out, with the final selection of partnerships to be announced by the end of 2020 at the latest.

EDCTP’s stakeholders have voiced broad and strong support for the EU-Africa Global Health Partnership as the EDCTP successor programme. As early as 2018, statements of support were made by several European member countries, including Portugal, the United Kingdom, France, Germany and Sweden. So far, 14 European countries and 11 African countries have expressed interest to participate in the new partnership. More countries are expected to step forward in the coming months.

stakeholders, including political leaders and public health policymakers, research communities, European and African universities and global health institutes, regulatory partners, product development partnerships, private sector partners and the World Health Organization, contributed with their thoughts and views to this draft proposal and research agenda. In December 2019, the draft proposal was submitted to the European Commission. Moreover, an online consultation involving African EDCTP Association members and other AU member countries not yet part of the partnership was launched to capture additional African views.

The Impact Assessment of the EU-Africa Global Health Partnership has now been reviewed by the European Commission’s Regulatory Scrutiny Board. To continue with the legislative approval process, the revised EU-Africa Global Health Partnership/EDCTP3 proposal will undergo the European Commission’s Inter-Service Consultation in the autumn.

We are happy to share here a short video with informal interviews conducted at the 11th European Congress on Tropical Medicine and International Health held on 16-20 September 2019 in Liverpool, the United Kingdom. This video is a snapshot of how partners interviewed see EDCTP and its contribution to global health. 

EDCTP looks forward to continuing to work for and take the final steps towards setting up this ambitious future programme, the EU-Africa Global Health Partnership/EDCTP3.

Compelling position papers with supportive viewpoints have been published:

About us

The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public–public partnership between 14 European and 16 African countries, supported by the European Union. EDCTP’s vision is to reduce the individual, social and economic burden of poverty-related infectious diseases by affecting sub-Saharan Africa. EDCTP’s mission is to accelerate the development of new or improved medicinal products for the identification, treatment and prevention of infectious diseases, including emerging and re-emerging diseases, through pre- and postregistration clinical studies, with emphasis on phase II and III clinical trials. Our approach integrates conduct of research with development of African clinical research capacity and networking. The second EDCTP programme is implemented by the EDCTP Association supported under Horizon 2020, the European Union’s Framework Programme for Research and Innovation.

Contact us

For more information, please contact us or leave a message using this form.
Please enter your name
Please enter a correct e-mail address
Please enter a comment
Thank you! Your message has been sent.
Something went wrong while submitting the form. Try again.

Share this publication

Forward this page by e-mail or share it directly on social media.


Enter a search term to search the EDCTP publications.
Minimal length to search is 3 characters

This publication uses cookies

We use functional and analytical cookies to improve our website. In addition, third parties place tracking cookies to display personalised advertisements on social media. By clicking accept you consent to the placement of these cookies.